Search research articles
Contact Us
Filters
Showing results (11-20 of 48) with videos related to
Page
of 5
Sort By:
Neuropeptides
|
January 21, 2019
Substance P-mediated cardiac mast cell activation: An in vitro study
Scott P Levick, Gregory L Brower, Joseph S Janicki
Pflugers Archiv : European Journal of Physiology
|
February 19, 2013
Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase
Joseph S Janicki, Francis G Spinale, Scott P Levick
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2014
The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling
Joseph S Janicki, Gregory L Brower, Scott P Levick
Heart, Lung & Circulation
|
April 4, 2015
Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure
Gregory L Brower, Scott P Levick, Joseph S Janicki
IJC Metabolic & Endocrine
|
January 2, 2016
THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS
Jianping Li, Shaiban Jubair, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 14, 2011
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype
Hong Lu, Giselle C Meléndez, Scott P Levick, et al.
Journal of Inflammation Research
|
September 25, 2013
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts
Jennifer L McLarty, Jianping Li, Scott P Levick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2007
Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation
Scott P Levick, David C Loch, Stephen M Taylor, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 6, 2010
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart
Scott P Levick, David B Murray, Joseph S Janicki, et al.
Journal of Molecular and Cellular Cardiology
|
April 21, 2010
Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha
David B Murray, Scott P Levick, Gregory L Brower, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 48) with videos related to
Sort By:
Page
of 5
Neuropeptides
|
January 21, 2019
Substance P-mediated cardiac mast cell activation: An in vitro study
Scott P Levick, Gregory L Brower, Joseph S Janicki
Pflugers Archiv : European Journal of Physiology
|
February 19, 2013
Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase
Joseph S Janicki, Francis G Spinale, Scott P Levick
Methods in Molecular Biology (Clifton, N.J.)
|
November 13, 2014
The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling
Joseph S Janicki, Gregory L Brower, Scott P Levick
Heart, Lung & Circulation
|
April 4, 2015
Differential Effects of Prevention and Reversal Treatment with Lisinopril on Left Ventricular Remodelling in a Rat Model of Heart Failure
Gregory L Brower, Scott P Levick, Joseph S Janicki
IJC Metabolic & Endocrine
|
January 2, 2016
THE AUTOCRINE ROLE OF TRYPTASE IN PRESSURE OVERLOAD-INDUCED MAST CELL ACTIVATION, CHYMASE RELEASE AND CARDIAC FIBROSIS
Jianping Li, Shaiban Jubair, Scott P Levick, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
December 14, 2011
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype
Hong Lu, Giselle C Meléndez, Scott P Levick, et al.
Journal of Inflammation Research
|
September 25, 2013
Estrogen modulates the influence of cardiac inflammatory cells on function of cardiac fibroblasts
Jennifer L McLarty, Jianping Li, Scott P Levick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 5, 2007
Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation
Scott P Levick, David C Loch, Stephen M Taylor, et al.
Hypertension (Dallas, Tex. : 1979)
|
January 6, 2010
Sympathetic nervous system modulation of inflammation and remodeling in the hypertensive heart
Scott P Levick, David B Murray, Joseph S Janicki, et al.
Journal of Molecular and Cellular Cardiology
|
April 21, 2010
Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha
David B Murray, Scott P Levick, Gregory L Brower, et al.
Page
of 5